Bio-Techne Corporation
TECHLast close · Oct 16, 202672.57+0.05 (+0.07%)
Market cap$11.4B
11 firms' latest targets, last 12 months: median $73.00 ($50.00–$79.00), 1% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-08-13 | Wells Fargo | $73.00 | — | +1% |
| 2026-06-26 | Stephens | $73.00 | — | +1% |
| 2026-06-26 | Baird | $73.00 | ▲ 49% | +1% |
| 2026-06-26 | Deutsche Bank | $73.00 | ▲ 1% | +1% |
| 2026-06-25 | Leerink Partners | $73.00 | — | +1% |
| 2026-06-11 | Piper Sandler | $65.00 | — | -10% |
| 2026-05-14 | RBC Capital | $62.00 | — | -15% |
| 2026-05-07 | Evercore ISI | $50.00 | ▼ 19% | -31% |
| 2026-05-07 | Stifel | $50.00 | ▼ 23% | -31% |
| 2026-02-05 | UBS | $79.00 | — | +9% |
| 2025-11-20 | Argus Research | $68.00 | — | -6% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2024reported | $1.2B | +2% | $1.05 | -40% | est. $1.2B-1% | est. $0.95 | 9 |
| 2025reported | $1.2B | +5% | $0.46 | -56% | est. $1.2B+0% | est. $1.90 | 10 |
| 2026reported | $1.2B | +0% | $1.16 | +152% | est. $1.2B+1% | est. $1.92 | 10 |
| 2027 | $1.3B | +4% | $2.03 | +6% | $1.2B–$1.3B | $1.96–$2.10 | 10 |
| 2028 | $1.4B | +10% | $2.38 | +17% | $1.4B–$1.4B | $2.29–$2.46 | 7 |
| 2029 | $1.6B | +13% | $2.43 | +2% | $1.5B–$1.6B | $2.35–$2.56 | 4 |
| 2030 | $1.7B | +9% | $2.67 | +10% | $1.7B–$1.8B | $2.58–$2.81 | 2 |
| 2031 | $2.0B | +14% | $0.00 | -100% | $1.9B–$2.0B | $0.00–$0.00 | 1 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.